Toxic Shock Syndrome
BASICS
DESCRIPTION
Toxic shock syndrome (TSS) is an acute febrile illness characterized by hypotension and gastrointestinal and respiratory distress progressing to multisystem organ failure. The clinical syndrome is caused by bacterial exotoxins produced by the following:
- Staphylococcus aureus TSS toxin-1 (TSST-1)–producing strains, referred to as TSS in this section
- Group A β-hemolytic streptococci (GAS or Streptococcus pyogenes), referred to as streptococcal toxic shock–like syndrome (STSS) in this section
- Rare cases have also been reported in association with groups B, C, and G1 streptococci and Streptococcus mitis.
EPIDEMIOLOGY
- TSS can be related to focal infections or retained foreign bodies.
- Previously linked to superabsorbent tampon use; menstrual-related TSS declined after increased public awareness.
- Currently, ~50% of cases are nonmenstrual related.
- STSS incidence is highest among young children.
- Associated with focal infections, pneumonia, or bacteremia
- Higher prevalence of STSS in developing countries
- Generally rare; sporadic cases affect <1 people per 100,000 per year.
RISK FACTORS
- Local or invasive staphylococcal or streptococcal infection including sinus, skin, soft tissue, and musculoskeletal and respiratory infections
- STSS most often occurs with skin and soft tissue infections, with preceding varicella infection being a known risk.
- Prolonged use of superabsorbent tampon, diaphragm, or contraceptive sponge
- Recent surgical or gynecologic procedure or postpartum wounds
GENERAL PREVENTION
- Scrupulous wound care
- Strict adherence to manufacturer’s directions for tampons and other intravaginal devices
- Early recognition and appropriate treatment of infections
PATHOPHYSIOLOGY
- Both S. aureus and S. pyogenes can produce exotoxins.
- Some exotoxins function as superantigens, interacting with immune cells to induce massive cytokine production leading to the predominant symptoms.
- Cytokines result in the hallmark findings of shock including fever, capillary leak, hypotension, and end-organ dysfunction.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Cabana, Michael D., editor. "Toxic Shock Syndrome." 5-Minute Pediatric Consult, 9th ed., Wolters Kluwer, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/617270/all/Toxic_Shock_Syndrome.
Toxic Shock Syndrome. In: Cabana MDM, ed. 5-Minute Pediatric Consult. Wolters Kluwer; 2025. https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/617270/all/Toxic_Shock_Syndrome. Accessed July 20, 2026.
Toxic Shock Syndrome. (2025). In Cabana, M. D. (Ed.), 5-Minute Pediatric Consult (9th ed.). Wolters Kluwer. https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/617270/all/Toxic_Shock_Syndrome
Toxic Shock Syndrome [Internet]. In: Cabana MDM, ed. 5-Minute Pediatric Consult. Wolters Kluwer; 2025. [cited 2026 July 20]. Available from: https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/617270/all/Toxic_Shock_Syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Toxic Shock Syndrome
ID - 617270
ED - Cabana,Michael D,
BT - 5-Minute Pediatric Consult
UR - https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/617270/all/Toxic_Shock_Syndrome
PB - Wolters Kluwer
ET - 9
DB - Pediatrics Central
DP - Unbound Medicine
ER -

5-Minute Pediatric Consult

